Europe’s drug regulatory agency reported that the storage period of the corona virus vaccine developed by BioNTech – Pfizer can be increased from five days to 31 days at normal refrigerator temperatures. The European Medicines Agency (EMA) stated that the vaccine can be easily distributed to non-refrigerated areas after this situation, and underlined that the change to be made applies to unopened vaccine bottles. The EMA observer informed Reuters that the announcement was made after…"BioNTech vaccine statement from the European Medicines Agency"
European Medicines Agency (EMA) officials held a press conference about the Covid-19 outbreak and vaccinations, providing information about the latest situation. Marco Cavaleri, responsible for EMA’s vaccination strategy, said that they continue to analyze data on variants, FROM at least of the vaccines used in mRNA vaccinations ” Indian variantHe said they saw that it was effective against. Cavaleri, stating that these vaccines will provide sufficient protection against the variant, “We think that viral vector…"European Medicines Agency: EU vaccines appear effective against Indian variant – Health News"
One of the cases following Johnson & Johnson vaccines occurred during clinical testing. At that time, the company said it found no evidence that the vaccine was faulty. Then, 3 more serious cases were seen in the USA, where vaccines were given to about 5 million people. However, although Johnson & Johnson’s vaccine has been approved in the EU, its availability is not expected to begin until later this month. Still, the EU holds high…"Investigation into Johnson Johnson’s corona virus vaccine from the European Union Agency (EMA) on the grounds that it causes blood clotting – Health News"
last minute “data-mce-href =” https://www.ntv.com.tr/son-dakika “> Breaking news! The European Medicines Agency (EMA), the European Union’s drug regulator, said the link between the Oxford / AstraZeneca vaccine and blood clots is possible. EMA highlighted that the benefits of the vaccine still outweigh the risks. The EMA concluded that blood coagulation should be listed as the ‘very rare’ side effect of the AstraZeneca vaccine, while the EMA’s safety committee noted that unusual blood clots with low…"LAST MINUTE NEWS: Astrazeneca statement from the European Medicines Agency – Health News"
Developed against corona virus Oxford-AstraZeneca vaccine, “Does it cause blood clotting?” on the agenda with the question. The European Medicines Agency (EMA) made a statement regarding the Covid-19 vaccine developed by Oxford University and AstraZeneca. The European Medicines Agency accepted claims for the vaccine, which was suspended in many countries due to concerns that it could cause blood clotting. It has been said that the blood coagulation seen in the patients is related to AstraZeneca.…"‘AstraZeneca’ statement from the European Medicines Agency – health news"
last minute “data-mce-href =” https://www.ntv.com.tr/son-dakika “> Breaking news! Details of last minute development are on ntv.com.tr soon … European Medicines Agency (EMA) discussed AstraZeneca made a statement about the vaccine. The European Medicines Agency stated that the AstraZeneca vaccine is “safe and benefits outweigh its risks.” The World Health Organization (WHO) also stated that the benefit of the AstraZeneca vaccine is greater than its risks and that the vaccination should continue."LAST MINUTE NEWS: AstraZeneca statement from the European Medicines Agency – Health News"
The European Medicines Agency (EMA), the European Union’s (EU) drug regulator, reported that the benefits of the Covid-19 vaccine AstraZeneca, which was discontinued in some European countries on the grounds that it causes blood clotting, outweighed the risks. EMA, which gathered to determine opinion after the use of the Covid-19 vaccine developed by AstraZeneca, was stopped in some countries, made a statement on the subject. In the statement, it was reported that the AstraZeneca vaccine,…"European Medicines Agency: Benefits of AstraZeneca vaccine outweigh risks"